The prognostic value of histological typing in nasopharyngeal carcinoma

Oral Oncology

Volumn 48, Issue 5, 2012, Pages 429-433

  Cheung, Florence ^a   Chan, Oscar ^a   Ng, Wai Tong ^a   Chan, Lucy ^a   Lee, Anne ^a   Pang, Siu Wah ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Clinical outcome; Differentiation; Excision repair cross complementation group 1 protein expression; Histological typing; Nasopharyngeal carcinoma; Non keratinizing; Prognostic value

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; PARAFFIN;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NASAL BIOPSY; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS;

EID: 84859961543     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.11.017     Document Type: Article

References (12)

1. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 1995;333(11):693-8.
2. Hong Kong Cancer Registry, Hospital Authority. Nasopharyngeal cancer. In: Hong Kong Cancer Stat 2007; 2007.
3. Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT, et al. Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma. Cochrane Database Syst Rev 2006;18(4):CD004329.
4. Chan SH, Cheung FM, Ng WT, Choi CW, Cheung KN, Yiu KH, et al. Can the analysis of ERCC1 expression contribute to individualized therapy in nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 2011;79(5):1414-20.
5. Chan JKC, Bray F, Mc Carron P, Foo W, Lee AWM, Yip T, et al. Nasopharyngeal carcinoma. In: Barnes EL, Eveson JW, Reichart P, Sdransky D, editors. Pathology and genetics of head and neck tumours. Kleihues P, Sobin LH, editors. World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2005. p. 85-97.
6. Wu TC, Mann RB, Epstein JI, MacMahon E, Lee WA, Charache P, et al. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalinfixed paraffin-embedded carcinoma specimens. Am J Pathol 1991;138(6):1461-9.
7. Saw D, Ho JH, Fong M, Chan CL, Tse CH, Lau WH. Prognosis and histology in stage I nasopharyngeal carcinoma (NPC). Int J Radiat Oncol Biol Phys 1985;11(5):893-8. (Pubitemid 15096653)
8. Reddy SP, Raslan WF, Gooneratne S, Kathuria S, Marks JE. Prognostic significance of keratinization in nasopharyngeal carcinoma. Am J Otolaryngol 1995;16(2):103-8.
9. Shanmugaratnam K, Chan SH, de-Thé G, Goh JE, Khor TH, Simons MJ, et al. Histopathology of nasopharyngeal carcinoma: correlations with epidemiology, survival rates and other biological characteristics. Cancer 1979;44(3):1029-44. (Pubitemid 10242239)
10. Olaussen KA, Dunant A, Fouret P, Brambilla E, André F, Haddad V, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 2006;355(10):983-91. (Pubitemid 44343542)
11. Sun JM, Ahn MJ, Park MJ, Lee HY, Ahn JS, Lee S, et al. Expression of excision repair cross-complementation group 1 as predictive marker for nasopharyngeal cancer treated with concurrent chemoradiotherapy. Int J Radiat Oncol Biol Phys 2011;80(3):655-60.
12. Lee HW, Hwang YH, Han JH, Choi JH, Kang SY, Jeong SH, et al. High expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with nasopharyngeal cancer. Oral Oncol 2010;46(3):209-13.